Secukinumab use in the treatment of Netherton's syndrome
Christian Gan, Emma King, David Orchard
Abstract
Netherton syndrome is a rare, severe genetic disorder of cornification without specific treatment. We describe two cases who demonstrated marked cutaneous improvement with secukinumab and suggest a role for IL-17 therapy in treating this condition.
Topics & Concepts
SecukinumabMedicineDermatologyPsoriasisPsoriatic arthritisSkin and Cellular Biology ResearchDermatology and Skin DiseasesCellular Mechanics and Interactions